METABOLIC TESTING MARKET ANALYSIS

Market Size and Trends

Global metabolic testing market is estimated to be valued at USD 726.2 Mn in 2024 and is expected to reach USD 1,188.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

To learn more about this report, request a free sample copy

The increasing prevalence of obesity and growing geriatric population are expected to boost demand for metabolic testing. Rising awareness about physical fitness and growing adoption of healthy lifestyle habits are also anticipated to boost the need for regular metabolic checks. The technological advancements in metabolic testing devices offering improved accuracy, fast results and portability can drive the market growth.

Increasing Launch of Metabolic Carts by Market Players

Global metabolic testing market is expected to witness significant growth over the forecast period, owing to increasing launches of new metabolic carts. For instance, in May 2021, Lumen, a healthtech company, in collaboration with San Francisco State University, Lumen had validated an ongoing study launched in 2020, which showed the validity of Lumen to detect changes in metabolic fuel utilization in a comparable manner with a laboratory standard metabolic cart, providing the ability for real-time metabolic information for users under any circumstances. Lumen has made metabolic testing accessible to measure metabolism from home via the CO₂ exhaled from the breath.

Market Concentration and Competitive Landscape

To learn more about this report, request a free sample copy

Global metabolic testing market is expected to witness significant growth over the forecast period, owing to increasing prevalence of lifestyle diseases such as type 2 diabetes, obesity, and cardiovascular diseases. For instance, on July 28, 2022, according to the data published by American Diabetes Association (ADA), around 37.3 million people in the U.S. suffered from diabetes in 2019. Whereas, nearly 1.9 million U.S. people had type 1 diabetes, including about 244,000 children and adolescents. Increasing prevalence of lifestyle diseases boosts demand for metabolic testing, and this can drive the global metabolic testing market growth.

To learn more about this report, request a free sample copy

Lifestyle diseases are still not considered as extremely serious and fatal in developed as well as emerging economies. Low awareness among people regarding metabolic testing is significantly restraining the growth of the global metabolic testing market. Metabolic testing provides essential insights about an individual's metabolic health by measuring their body's ability to process energy, balance nutrients, and eliminate toxins. However, most people have very little understanding of what metabolic testing encompasses and how important it is for their overall well-being. Due to the lack of awareness, people do not seek metabolic testing voluntarily and even if doctors recommend it, patients remain hesitant to undergo these tests. They often perceive metabolic tests to be complex, tedious procedures requiring fasting, whereas modern testing methods have made the experience more convenient. This hinders the uptake of metabolic testing services. As a result, several underlying metabolic dysfunctions and nutritional deficiencies may remain undiagnosed. Over time, this can increase the risks of developing serious health issues like diabetes, obesity, cardiovascular diseases, and cancer.

Market Opportunity – Increasing Adoption of New Technologies in Metabolic Testing Devices

Increasing adoption of new technologies in metabolic testing devices is expected to drive growth of the global metabolic testing market. In May 2022, Mayo Clinic, a medical center focused on integrated health care, education, and research, developed a new app for Apple, a multinational technology company, using artificial intelligence to detect left-ventricular dysfunction, a life-threatening, asymptomatic heart disease. The introduction of ArtificiaI intelligence to 12 lead ECG (Electrocardiogram) analysis in a clinical setting enabled the ECG to identify left ventricular dysfunction. The technology has the potential to be scaled and adopted by hospital systems to better serve patients, particularly in remote communities or geographically diverse populations around the world.

To learn more about this report, request a free sample copy

Product Type segment is sub-segmented into metabolic carts, body composition analyzers, ECGs/EKGs. Metabolic Carts segment is estimated to hold 48.2% of the market share in 2024, owing to their convenience and versatility. Metabolic carts are modular systems equipped with a variety of metabolic testing instruments that can be easily wheeled to the location of the patient. This allows for metabolic tests to be conducted conveniently in settings such as hospital beds, clinics, training facilities and even at home. Being modular in nature, metabolic carts can be customized with a selection of devices depending on the specific needs of end users. Common devices installed on metabolic carts include ECG/EKG machines, gas analyzers, breath-by-breath systems and body composition analyzers

Insights, By Service Type: RMR Analysis dominance stems from foundational metabolic testing needs

Service Type segment is sub-segmented into VO2 MAX ANALYSIS, RMR analysis, body composition analysis. RMR Analysis  segment is estimated to hold 39.5% of the market share in 2024, due to serving as a foundation for various metabolic assessments. BMR, which stands for basal metabolic rate, is considered one of the most basic tests to evaluate an individual's metabolism. It measures the minimum energy requirement of the body at rest. Determining BMR serves as an essential starting point for calculating daily calorie needs and developing targeted diet and exercise plans. BMR Analysis continues to account for a bulk of metabolic testing demand given its role as a baseline indicator across diverse patient profiles and settings. It is universally applicable for monitoring metabolic health and fitness levels in populations ranging from normal adults and athletes to chronically ill patients and the elderly. Due to being a foundational metric, regular BMR tests are prescribed for tracking longitudinal changes during clinical therapy, wellness programs and sports training regimens. The availability of convenient calorimeter-based BMR analysis instruments suited for various environments, from hospital facilities to gyms, have widened the customer base.

Insights, By End User: The Strengths of Specialized Infrastructure and Talent Pool Available in Clinical Environments

The end user segment is sub-segmented into hospitals and clinics, sports performance lab, home care settings. Hospitals and clinics  segment is estimated to hold 37.4% of the market share in 2024, owing to the strengths of specialized infrastructure and talent pool available in clinical environments. Hospitals and clinics serving diverse patient populations require in-depth metabolic profiling for applications such as assessing chronic disease severity, monitoring therapeutic impact, and preventive health screening. Their standing as premier healthcare facilities and access to advanced metabolism laboratories, equipment and expert technicians drive significant testing volume through their portals. Clinical settings are uniquely resourced with sophisticated metabolic analyzers, specialized spaces dedicated for stress tests and body composition evaluations, along with respiratory monitoring systems needed for detailed cardiopulmonary assessments.

Regional Insights

To learn more about this report, request a free sample copy

North America remains the dominant region in the global metabolic testing market and is estimated to hold 42.6% of the market share in 2024. With presence of major payers and providers, sophisticated healthcare infrastructure, and focus on preventive healthcare, North America offers lucrative opportunities for metabolic testing providers. The U.S., in particular, contributes significantly to the regional market size, owing to growing prevalence of lifestyle diseases and focus on early disease diagnosis. Favorable reimbursement policies have encouraged patients to regularly undergo metabolic tests. Rising health awareness among consumers have also prompted them to opt for preventive health measures like metabolic testing.

The metabolic testing market in the Asia Pacific region has been witnessing exponential growth over the past few years. Rapid economic development and improving access to advanced healthcare services are some key factors driving the market growth. Especially countries like China, Japan and India have emerged as highly lucrative markets. Rising focus on fitness and weight management have boosted demand for various metabolic tests in Asia Pacific. Governments are also introducing various initiatives to modernize healthcare infrastructure and strengthen preventive diagnostic capabilities. This has encouraged local as well as global market players to tap into opportunities by establishing manufacturing and distribution network across Asia Pacific countries. Growing medical tourism across the region have attracted patients from other parts of the world.

Market Report Scope

Key Developments

• On March 7, 2024, Labcorp, a global leader of innovative and comprehensive laboratory services, launched its Weight Loss Management portfolio. The new offering features educational resources and convenient testing solutions, equipping individuals and their physicians with baseline and ongoing health indicators to inform treatment options, including lifestyle modifications, Glucagon-like peptide-1 (GLP-1) medications or bariatric surgery.
• In January 2022, Koninklijke Philips N.V., a global health technology company, launched 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution enables patient-centric ECG offering within the company’s cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips, a cloud-based data collection and analysis services company, which in turns helps to drive innovation across the care continuum and support the decentralized clinical trial space.
• In November 2020, Lumen Technologies, a medical technology company, announced the U.K. launch of its personalized nutrition device that enables the fine-tuning of nutritional intake via real-time metabolic tracking

*Definition: Metabolic testing involves assessment of health and wellbeing of an individual. Metabolic testing equipment are used to screen organ functions and disease conditions such as liver diseases, diabetes, kidney diseases, and cardiovascular diseases. Metabolism is a chemical reaction occurring in the body to maintain the standard state of the organism or body. Metabolic syndrome is a group of metabolic disorders such as high blood pressure with high fasting glucose levels and abnormal obesity. Metabolism pattern and metabolic capacity is determined with the help of metabolic testing for management of such conditions. In case of sports professionals, metabolic testing is done in order to test the body’s ability of oxygen consumption.

Market Segmentation

•  Product Type Insights (Revenue, USD Mn, 2019 - 2031)
  • Metabolic Carts
  • Body Composition Analyzers
  • ECGs/EKGs
•  Test Type Insights (Revenue, USD Mn, 2019 - 2031)
  • VO2 Max Analysis
  • RMR Analysis
  • Body Composition Analysis
•  End User Insights (Revenue, USD Mn, 2019 - 2031)
  • Hospitals and Clinics
  • Sports Performance Lab
  • Home Care Settings
• Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • COSMED srl
  • Vyaire Medical, Inc.
  • Geratherm Medical AG
  • MGC Diagnostics Corporation
  • CORTEX Biophysik GmbH
  • Microlife Medical Home Solutions, Inc.
  • OSI Systems, Inc.
  • AEI Technologies, Inc.
  • KORR Medical Technologies, Inc.
  • Iworx Systems
  • GE Healthcare
  • Hologic, Inc
  • Koninklijke Philips N.V.